AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
AdaptHealth Corp.NASDAQ: AHCO
Cash & Equivalents · Q1 FY2026 · quarter ended Apr 2026
Cash & equivalents falls 10.6% from a year ago
Cash & equivalents stood at $47.96M at the end of Q1 FY2026, down 10.6% from a year earlier and down 54.8% from the prior quarter. Over 3 fiscal years it compounded at +31.9% a year.
Context
- Cash & equivalents amounted to 1.1% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -10.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 106.14M USD
- Year-over-year change
- -3.3%
- 4-year CAGR
- -8.2%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 106.14M | -3.3% |
| FY2024 | 2024-12-31 | 109.75M | +42.3% |
| FY2023 | 2023-12-31 | 77.13M | +66.7% |
| FY2022 | 2022-12-31 | 46.27M | -69.1% |
| FY2021 | 2021-12-31 | 149.63M | — |
Cash & Equivalents vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's Apr 2026 cash & equivalents of $47.96M is the 5th highest of the 9 companies compared; the peer median is $62.31M.
- Its year-over-year change of -10.6% is the 7th highest of 9, against a peer median of +15.5%.
- Cash & equivalents amounts to 1.1% of total assets for AHCO, versus a peer median of 14.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.47B | +21.5% | +86.1% | 16.4% | |
| Mar 2026 | $179.33M | +234.7% | -19.3% | 15.5% | |
| Jun 2026 | $127.76M | +19.5% | -38.1% | 13.8% | |
| Mar 2026 | $94.41M | -20.6% | -17.8% | 33.0% | |
| Apr 2026 | $47.96M | -10.6% | +31.9% | 1.1% | |
| Mar 2026 | $30.21M | -28.9% | +4.5% | 9.9% | |
| Mar 2026 | $16.99M | +11.5% | +23.3% | 28.6% | |
| Mar 2026 | $9.76M | -3.9% | -7.2% | 4.9% | |
| Mar 2026 | $2.11M | +39.8% | +168.3% | 2.1% | |
| Peer median (excluding AHCO) | $62.31M | +15.5% | -1.4% | 14.7% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 149.63M | 46.27M | 77.13M | 109.75M | 106.14M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 359.9M | 359.15M | 388.91M | 408.02M | 370.9M |
| Inventory | 123.1M | 127.75M | 113.64M | 139.84M | 151.25M |
| Other Current Assets | 0 | 52.14M | 69.34M | 98.18M | 0 |
| Total Current Assets | 670.06M | 585.31M | 649.02M | 755.79M | 728.9M |
| Property, Plant & Equipment (Net) | 546.34M | 622.01M | 637.53M | 618.36M | 674.22M |
| Goodwill | 3.51B | 3.55B | 2.72B | 2.68B | 2.54B |
| Intangible Assets | 202.23M | 162.77M | 130.16M | 105.55M | 85.12M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 304.19M | 281.79M | 345.85M | 314.51M | 267.79M |
| Other Non-current Assets | 15.1M | 22.42M | 21.13M | 17.58M | 19.12M |
| Total Non-current Assets | 4.58B | 4.63B | 3.86B | 3.73B | 3.59B |
| Total Assets | 5.25B | 5.22B | 4.51B | 4.49B | 4.32B |
| Account Payables | 248.03M | 222.51M | 211.5M | 284.6M | 352.38M |
| Short-term Debt | 20M | 35M | 53.37M | 16.25M | 20.31M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 31.37M | 31.64M | 38.57M | 34.94M | 59.84M |
| Other Current Liabilities | 43.19M | 19.86M | 14.68M | 33.55M | 79.91M |
| Total Current Liabilities | 499.81M | 456.21M | 537M | 566.99M | 712.39M |
| Long-term Debt | 2.18B | 2.15B | 2.09B | 1.96B | 1.72B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 380.25M | 344M | 302.09M | 272.02M | 243.8M |
| Total Non-current Liabilities | 2.68B | 2.61B | 2.5B | 2.34B | 2.08B |
| Total Liabilities | 3.18B | 3.06B | 3.04B | 2.91B | 2.79B |
| Common Stock | 13K | 13K | 13K | 13K | 13K |
| Retained Earnings | (43.02M) | 26.3M | (652.6M) | (562.18M) | (632.97M) |
| Accumulated OCI | (2.35M) | 8.69M | 4.36M | 2.25M | 78K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.78M | 6.6M | 8.22M | 6.97M | 7.76M |
| Total Equity | 2.07B | 2.16B | 1.47B | 1.58B | 1.53B |
| Total Debt | 2.37B | 2.33B | 2.29B | 2.13B | 1.9B |
| Net Debt | 2.22B | 2.28B | 2.22B | 2.02B | 1.8B |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.